Workflow
obesity
icon
Search documents
Nutritionist and Molecular Biologist on RFK Jr.’s MAHA Agenda, Processed Foods and More | WSJ
WSJ News· 2025-09-23 16:37
Food Industry & Public Health - The food industry is not a social service or public health agency, but a business with stockholders to please, prioritizing the bottom line [5] - The food industry is currently under pressure from multiple factors, including concerns about ultra-processed foods, RFK Jr's actions, and the rise of GLP-1 drugs [30] - GLP-1 drugs are perceived as detrimental to the food industry because they reduce "food noise," leading to decreased consumption and a preference for smaller portions with more protein and vitamins [28][29][30] Regulatory Landscape & Policy Recommendations - Regulation is considered central to improving children's health, particularly in areas like marketing to children and removing ultra-processed foods from schools [4][14] - The speaker suggests universal school meals to ensure all children have access to healthy food at least twice a day [15] - Recommends changing the agricultural system to prioritize food for people over commodity foods [15] - The speaker advocates for warning labels on ultra-processed foods, similar to those used in Latin American countries [26] Dietary Trends & Nutritional Perspectives - The levels of obesity among children are staggering, with 20% to 30% being overweight or obese [18] - The speaker believes that eating less is crucial for addressing calorie intake and weight issues, but this is bad for the food industry's business model [8] - The speaker does not take supplements, believing that a varied diet of relatively unprocessed foods is sufficient for obtaining necessary vitamins [58][59][60] Food Insecurity & Accessibility - The speaker highlights the issue of food insecurity in America and the potential impact of discontinuing its measurement [43][44][45] - The speaker notes that while it's now possible to eat healthfully anywhere in the US, affordability and access to cooking facilities remain significant challenges [39][43]
X @The Wall Street Journal
Industry Trend - Weight-loss drugs like Ozempic are seen as a potential solution to obesity [1] Social Impact - Fat activists are posing a challenge to the use of weight-loss drugs [1]
X @The Wall Street Journal
Industry Trend - Weight-loss drugs like Ozempic are seen as a potential solution to obesity [1] Social Impact - Fat activists are posing a challenge to the use of weight-loss drugs [1]
X @The Wall Street Journal
Ozempic and other weight-loss drugs may be a promising solution to the growing problem of obesity, but they’ve got a surprising foe: fat activists. https://t.co/wdC7XHm73J ...
X @The Economist
The Economist· 2025-08-20 15:00
“Even if every person living with obesity took medicines, we couldn’t treat our way out of this crisis,” warns Lars Fruergaard Jørgensen. In a guest essay he argues that “the world must prioritise prevention” https://t.co/W27aUCTPmDIllustration: Dan Williams https://t.co/TW0zerNZjd ...
X @The Wall Street Journal
Industry Trend - Weight-loss drugs like Ozempic are seen as a potential solution to the increasing obesity issue [1] Social Impact - Fat activists are posing a challenge to the widespread acceptance of weight-loss drugs [1]
X @The Wall Street Journal
Industry Trend - Weight-loss drugs like Ozempic are seen as a potential solution to obesity [1] Potential Challenges - Fat activists are posing a challenge to the widespread acceptance of weight-loss drugs [1]
X @The Wall Street Journal
One side believes it can help people overcome obesity; the other wants to shift the focus from changing their bodies to helping them live in themhttps://t.co/ZuLA3FFYH6 https://t.co/XRO020BPpk ...
X @The Economist
The Economist· 2025-08-11 18:20
“Even if every person living with obesity took medicines, we couldn’t treat our way out of this crisis,” warns Lars Fruergaard Jørgensen. In a guest essay he argues that “the world must prioritise prevention” https://t.co/B5FT3Y6igl ...
Eli Lilly’s obesity pill led to around 12% weight loss in late-stage trial, paving way for approval
CNBC Television· 2025-08-07 12:09
news uh that we've I guess been waiting for from Eli Liy. Got a look at the stock. Uh although we'll show you that Angelica Peeles that's here and joins us now, but uh as you're talking, we should take a quick look at the uh early morning action in the shares.But take it away. >> Yeah, that early morning action not good. The stock down about 6% right now and that's after we got this highly anticipated data on its obesity pill and clearly there's some disappointment.So let's go through the numbers. people lo ...